Sagimet Biosciences

Series-A
sagimet.com Biotech & Healthcare
Total Funding $25M
Latest Round Undisclosed Series-A
Last Announced Apr 29, 2026
Investors Undisclosed
Decision Makers Profile Active

About Sagimet Biosciences

We are a clinical-stage biopharmaceutical company advancing a portfolio of novel fatty acid synthase (FASN) inhibitors. FASN is a key […]

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website sagimet.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $7,000,000 · Series-B

    startupintros.com

  3. Capital Raise

    Raised $18,000,000 · Series-B

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Sagimet Biosciences.

Funding History

3 Rounds
Series-A equity · Apr 29, 2026
Series-B equity · Aug 1, 2019
Series-B equity · Feb 13, 2019

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts